✦ LIBER ✦

EN2 is a candidate oncogene in human breast cancer

✍ Scribed by Martin, Nicole L; Saba-El-Leil, Marc K; Sadekova, Svetlana; Meloche, Sylvain; Sauvageau, Guy

Book ID: 110069883
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 690 KB
Volume: 24
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1208840

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessing sequential oncogene amplificat

Assessing sequential oncogene amplification in human breast cancer

✍ Laura E. Janocko; Joseph F. Lucke; David W. Groft; Kathryn A. Brown; Charles A. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

## Abstract Studies of amplification and/or overexpression of c‐myc, HER‐2/neu, and H‐ras in breast cancer have shown that each is associated with a poor prognosis. The purpose of this study was to explore the possibility that there is a preferred sequence of amplification of these oncogenes in bre

Oncogene expression is modulated by reco

Oncogene expression is modulated by recombinant human interferon-β in human breast-cancer cells

✍ Gigliola Sica; Cristiana Angelucci; Luca Marini; Ferdinando Milazzo; Silvia Doni 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 717 KB

The effect of recombinant human interferon$ on growth and oncoprotein expression was investigated in several human breast-cancer cell lines with different characteristics. All cell lines tested were sensitive to the antiproliferative action of the drug, regardless of their estrogen sensitivity. The

Overexpression of the Tpl-2/Cot oncogene

Overexpression of the Tpl-2/Cot oncogene in human breast cancer

✍ Sourvinos, G; Tsatsanis, C; Spandidos, D A 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 269 KB

PCDH8, the human homolog of PAPC, is a c

PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer

✍ Yu, J S; Koujak, S; Nagase, S; Li, C-M; Su, T; Wang, X; Keniry, M; Memeo, L; Roj 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 374 KB

ZNF217, a candidate breast cancer oncoge

ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells

✍ Krig, S R; Miller, J K; Frietze, S; Beckett, L A; Neve, R M; Farnham, P J; Yaswe 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 692 KB

Human E2F5 gene is oncogenic in primary

Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors

✍ Jolanta Polanowska; Laurent Le Cam; Béatrice Orsetti; Heléne Vallés; Eric Fabbri 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

E2F transcription factors (E2F1 to 6) are central players in the control of animal cell proliferation as regulators of genes involved in cell cycle progression and in transformation. In this report, we have investigated the potential involvement of the E2F5 gene in tumorigenesis. We show that E2F5 c